Suppr超能文献

重组组织型纤溶酶原激活剂初始推注量对日本急性心肌梗死患者冠状动脉再通及梗死面积的影响。熊本大学心肌梗死研究(KUMIS)组。

Effect of the initial bolus volume of recombinant tissue-type plasminogen activator on coronary recanalization and infarct size in Japanese acute myocardial infarction patients. Kumamoto University Myocardial Infarction Study (KUMIS) Group.

作者信息

Ogawa H, Yasue H, Oshima S, Ogata Y, Numata Y, Fujimoto K, Imoto N, Saito T, Hokamura Y, Takahashi T

机构信息

Division of Cardiology, Kumamoto University School of Medicine, Japan.

出版信息

Jpn Circ J. 1995 Oct;59(10):663-72. doi: 10.1253/jcj.59.663.

Abstract

Coronary recanalization rate and infarct size were compared between 2 different methods of intravenously administering recombinant tissue-type plasminogen activator (rt-PA) 41.4 mg; 1) an initial bolus dose of 30% followed by infusion of the remainder over 60 min (30% group), and an initial bolus dose of 10% followed by infusion of the remainder over 60 min (10% group). Thirty min after beginning rt-PA infusion, the coronary recanalization rate was higher in the 30% group than in the 10% group (82.9% (34/41) vs 53.7% (22/41), p < 0.01). The peak creatine kinase and peak creatine kinase-MB levels were lower in the 30% group than in the 10% group. We conclude that a higher initial bolus dose of rt-PA gives a higher rate of recanalization of the infarct-related artery at the very early phase, and probably leads to a smaller infarct size.

摘要

比较了两种不同方法静脉注射41.4毫克重组组织型纤溶酶原激活剂(rt-PA)后的冠状动脉再通率和梗死面积;1)初始推注剂量为30%,其余剂量在60分钟内输注(30%组),以及初始推注剂量为10%,其余剂量在60分钟内输注(10%组)。开始rt-PA输注30分钟后,30%组的冠状动脉再通率高于10%组(82.9%(34/41)对53.7%(22/41),p<0.01)。30%组的肌酸激酶峰值和肌酸激酶-MB峰值水平低于10%组。我们得出结论,较高的rt-PA初始推注剂量在极早期可使梗死相关动脉的再通率更高,并且可能导致梗死面积更小。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验